Pharmafile Logo

Webinar: How to conduct effective market research in emerging markets

March 31, 2015 | emerging markets, market research 

Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.

In this webinar, Associate Directors Paul Reed and Rachel Howard, using examples from a wide range of emerging markets, we will explain the important cultural, methodological and quality considerations and provide you with the core critical success factors to guaranteeing effective primary research in emerging markets.

1. Understand the environment
We will consider how both internal and external variables may influence market selection and sample composition.

2. Select the best execution method
We will explain how research approaches need to be tailored to take account of infrastructural, communication and cultural differences across emerging markets.

3. Ensure quality and compliance
We will explore the importance of building rigorous quality controls into the project 

To view this webinar please visit http://bit.ly/1Iusvea 

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Free Thinking: Behavioural economics

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

Published in eye for pharma 12 December by Marc Yates

Exploring MINT: Part 4 - Turkey

In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in...

Getting to grips with Russia’s healthcare market

As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn't...

Exploring MINT: Part 3 - Nigeria

In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.

Exploring MINT: Part 2 - Indonesia

In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...

Free Thinking: Leveraging the ASEAN Market

If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to...

Free Thinking: Biosimilars: Friend or foe to healthcare?

Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.